Internal Reference Number: FOI_6607
Date Request Received: 27/05/2022 00:00:00
Date Request Replied To: 22/06/2022 00:00:00
This response was sent via: By Email
Request Summary: Treatment drugs
Request Category: Private Individuals
| Question Number 1: How many patients were treated by your Trust (for any condition) in the last 3 months with the following drugs: Adalimumab (Amgevita) Adalimumab (Humira) Adalimumab (Hyrimoz) Adalimumab (Idacio) Adalimumab (Imraldi) | |
| Answer To Question 1: Amgevita 171 Humira 38 Hyrimoz 0 Idacio 0 Imraldi 141 | |
| Question Number 2: How many patients were treated in the last 3 months by the Rheumatology department (for any condition) with the following drugs: Adalimumab (Amgevita) Adalimumab (Humira) Adalimumab (Hyrimoz) Adalimumab (Idacio) Adalimumab (Imraldi) | |
| Answer To Question 2: Amgevita 160 Humira 27 Hyrimoz 0 Idacio 0 Imraldi 69 | |
| Question Number 3: How many patients were treated in the last 3 months by the Dermatology department (for any condition) with the following drugs: Adalimumab (Amgevita) Adalimumab (Humira) Adalimumab (Hyrimoz) Adalimumab (Idacio) Adalimumab (Imraldi) | |
| Answer To Question 3: Amgevita <5 Humira 6 Hyrimoz 0 Idacio 0 Imraldi 21 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
